Popular Articles
Teeth Whitening

As Obama Wades Into Health Debate, Tough Choices Await
"As the legislative debate over health care intensifies on Capitol Hill, there is growing clamor for President Obama to step in," the Washington Post reports. The administration has so far left the crafting of legislation in the hands of Congress, but a series of tough choices await the President, who at some point must define "what he"ll accept and what he won"t" in a final bill. His job is made more difficult by recent cost estimates. "A preliminary estimate of the Senate Finance Committee"s draft bill put the price tag of universal coverage at $1.6 trillion over 10 years. That was considerably more than anyone anticipated and forced the committee to delay work on the bill. The cost of the incomplete plan drafted by the Senate Health, Education, Labor and Pensions Committee was pegged at about $1 trillion over 10 years, but the CBO said that would still leave 30 million (rather than the current 46 million) people without coverage."
generic viagra online
Spiration Announces The Participation Of Several New Sites In U.S. Pivotal Trial Of Minimally Invasive Treatment For Severe Emphysema
Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, announced today that several new clinical sites are now actively recruiting patients for participation in a pivotal trial of the company"s minimally invasive treatment for severe emphysema.
News of the day
Studying The Anti-Cancer Capabilities Of A Special Purple Sweet Potato
A Kansas State University researcher is studying the potential health benefits of a specially bred purple sweet potato because its dominant purple color results in an increased amount of anti-cancer components.
Cardiovascular

As Immunosuppression Grows, AIDS Patients Face Higher Risk Of HPV-Related Cancers

Risk of human papillomavirus (HPV)-associated cancers is greater for people living with AIDS and increases with increasing immunosuppression, according to a new study published online July 31 in the Journal of the National Cancer Institute. Although the risk of HPV-associated cancers is known to be higher among people with AIDS, the extent to which HIV-related immunosuppression plays a role is unclear. Anil K. Chaturvedi, Ph.D., of the Infections and Immunoepidemiology Branch at the National Cancer Institute, in Rockville, Md., and colleagues used data from a cancer registry for almost 500,000 persons diagnosed with AIDS between 1980 and 2004 to estimate risks for HPV-associated cancers. These include cancers of the anus, cervix, oropharynx, penis, vagina, and vulva. The researchers also evaluated the relationship between immunosuppression and incidence of these cancers by counting CD4 T-cells at AIDS onset. Incidence was compared across three periods (1980-, 1990-, and 1996-). People with AIDS had a statistically significant higher risk for all HPV-associated cancers. From 1996 (when highly active antiretroviral therapy was introduced) through 2004, a low CD4 T-cell count was associated with an increased risk of invasive anal cancer among men. This risk was higher in 1996- than in 1990-. Both increases in risk were statistically significant. "Given that individuals currently infected with HIV may obtain little benefit from available HPV vaccinesò€¦our results underscore the need for effective screening for cervical cancer and anal cancer among persons with HIV infection or AIDS," the authors write. In an accompanying editorial, Howard D. Strickler, M.D., of Albert Einstein College of Medicine, Department of Epidemiology & Population Health, said the study provides novel evidence associating HPV-related invasive cancers with the level of immunosuppression in HIV-positive patients. However, he also cautioned that while highly suggestive the available data to date collectively still fall short of proving a biological relationship between HIV/AIDS and HPV-related cancers. Regarding the study by Chaturvedi et al, for example, after mentioning several important strengths to that study, Dr. Strickler also mentions: "Nonetheless, it must additionally be acknowledged that these associations between human papillomavirus-related cancers and markers of immunosuppression were of moderate strength, varied between cancer types, and await confirmation." Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):